نتایج جستجو برای: 52 high week

تعداد نتایج: 2230247  

2015
Haoda Fu Dachuang Cao Kristina S. Boye Bradley Curtis Dara L. Schuster David M. Kendall Haya Ascher-Svanum

INTRODUCTION American Diabetes Association consensus guidelines emphasize individualized treatment in the management of type 2 diabetes mellitus (T2DM). Early glycemic response is a clinical marker that may predict longer term efficacy for individual patients and provide a clinical tool to enhance personalized treatment. This analysis evaluated whether glycemic response measured at week 12 ("ea...

2014
Vibeke Strand Roger A Levy Ricard Cervera Michelle A Petri Helen Birch William W Freimuth Z John Zhong Ann E Clarke

OBJECTIVE Assess the effects of belimumab treatment plus standard systemic lupus erythematosus (SLE) therapy on health-related quality of life (HRQOL) in patients with active, autoantibody-positive SLE. METHODS Patients received standard therapy plus placebo or belimumab 1 or 10 mg/kg in two multicentre, randomised controlled trials of 52 (BLISS-52; N=865) and 76 (BLISS-76; N=819) weeks' dura...

2017
K. Reich M. Gooderham L. Green A. Bewley Z. Zhang I. Khanskaya R.M. Day J. Goncalves K. Shah V. Piguet J. Soung

BACKGROUND Apremilast, an oral, small-molecule phosphodiesterase 4 inhibitor, has demonstrated efficacy in patients with moderate-to-severe psoriasis. OBJECTIVE Evaluate efficacy and safety of apremilast vs. placebo in biologic-naive patients with moderate-to-severe plaque psoriasis and safety of switching from etanercept to apremilast in a phase IIIb, randomized, double-blind, placebo-contro...

2016
Tatsuya Atsumi Kazuhiko Yamamoto Tsutomu Takeuchi Hisashi Yamanaka Naoki Ishiguro Yoshiya Tanaka Katsumi Eguchi Akira Watanabe Hideki Origasa Shinsuke Yasuda Yuji Yamanishi Yasuhiko Kita Tsukasa Matsubara Masahiro Iwamoto Toshiharu Shoji Toshiyuki Okada Désirée van der Heijde Nobuyuki Miyasaka Takao Koike

OBJECTIVES To evaluate efficacy and safety of combination therapy using certolizumab pegol (CZP) and methotrexate (MTX) as first-line treatment for MTX-naive, early rheumatoid arthritis (RA) with poor prognostic factors, compared with MTX alone. METHODS MTX-naive, early RA patients with ≤12 months persistent disease, high anti-cyclic citrullinated peptide, and either rheumatoid factor positiv...

Journal: :Clinical chemistry 2013
Karl B Scheidweiler David M Schwope Erin L Karschner Nathalie A Desrosiers David A Gorelick Marilyn A Huestis

BACKGROUND Blood and plasma cannabinoid stability is important for test interpretation and is best studied in authentic rather than fortified samples. METHODS Low and high blood and plasma pools were created for each of 10 participants after they smoked a cannabis cigarette. The stabilities of Δ(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), cannabi...

2015
Christopher P. Cannon Bertrand Cariou Dirk Blom James M. McKenney Christelle Lorenzato Robert Pordy Umesh Chaudhari Helen M. Colhoun

AIMS To compare the efficacy [low-density lipoprotein cholesterol (LDL-C) lowering] and safety of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin 9, compared with ezetimibe, as add-on therapy to maximally tolerated statin therapy in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia. METHODS AND RESULTS COMBO II is a do...

2009
C A Wijbrandts S I van Leuven H D Boom D M Gerlag E G S Stroes J J P Kastelein P P Tak

BACKGROUND Macrophage migration inhibitory factor (MIF) has recently emerged as an important cytokine possibly linking rheumatoid arthritis (RA) and atherogenesis. Because atherogenesis is accelerated in RA this study was conducted to investigate whether anti-tumour necrosis factor (TNF) therapy could lead to sustained downregulation of systemic MIF levels and improvement in lipid profiles. M...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید